Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice

Biological Research
Susana Contreras-DuarteAttilio Rigotti

Abstract

Atherosclerotic cardiovascular disease is highly prevalent and its underlying pathogenesis involves dyslipidemia including pro-atherogenic high density lipoprotein (HDL) remodeling. Vitamins C and E have been proposed as atheroprotective agents for cardiovascular disease management. However, their effects and benefits on high density lipoprotein function and remodeling are unknown. In this study, we evaluated the role of vitamin C and E on non HDL lipoproteins as well as HDL function and remodeling, along with their effects on inflammation/oxidation biomarkers and atherosclerosis in atherogenic diet-fed SR-B1 KO/ApoER61h/h mice. Mice were pre-treated for 5 weeks before and during atherogenic diet feeding with vitamin C and E added to water and diet, respectively. Compared to a control group, combined vitamin C and E administration reduced serum total cholesterol and triglyceride levels by decreasing apo B-48-containing lipoproteins, remodeled HDL particles by reducing phospholipid as well as increasing PON1 and apo D content, and diminished PLTP activity and levels. Vitamin supplementation improved HDL antioxidant function and lowered serum TNF-α levels. Vitamin C and E combination attenuated atherogenesis and increased lifespa...Continue Reading

References

Jan 1, 1987·Annals of the New York Academy of Sciences·E Niki
Feb 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·I JialalB A Huet
May 20, 1993·The New England Journal of Medicine·E B RimmW C Willett
Aug 18, 2000·Free Radical Biology & Medicine·S R Thomas, R Stocker
Mar 20, 2001·Atherosclerosis·J HuuskonenC Ehnholm
Mar 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Takuya MatsumotoZvonimir S Katusic
May 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anne BraunMonty Krieger
Jul 12, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Xiao Ping YangXian-Cheng Jiang
Aug 16, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Anatol KontushM John Chapman
Mar 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Anatol Kontush, M John Chapman
Oct 12, 2007·Journal of Lipid Research·David T ValentaLinda K Curtiss
Jan 15, 2010·Journal of Lipid Research·Kenneth R Feingold, Carl Grunfeld
Jun 19, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Vladimir R BabaevJames M May
Jun 15, 2011·Free Radical Biology & Medicine·Maret G Traber, Jan F Stevens
Oct 1, 2011·Journal of Lipid Research·Theodoros KelesidisOtto O Yang
Nov 10, 2012·Diabetes Research and Clinical Practice·Hiroshi MurakamiToshihiro Suda
Jan 17, 2013·Biochimica Et Biophysica Acta·Ivana SreckovicChristian Wadsack
Apr 29, 2015·International Journal of Cardiology·Francis O'NeillJohn Deanfield
May 23, 2015·Journal of Lipid Research·Tomáš VaisarJay W Heinecke
Jul 16, 2015·Canadian Journal of Physiology and Pharmacology·Srikanth GivvimaniSuresh C Tyagi
May 23, 2017·Cardiovascular Diagnosis and Therapy·Ian M GrahamNathan D Wong
Aug 5, 2017·Current Opinion in Lipidology·Graziella E Ronsein, Jay W Heinecke
Aug 24, 2017·Journal of Lipid Research·Francesca ZimettiGraziana Lupattelli
Jan 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Yi HeKarin E Bornfeldt
Mar 17, 2018·Current Medicinal Chemistry·Alice OssoliMonica Gomaraschi

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
immunoprecipitation
ELISA

Software Mentioned

Element
GraphPad Prism
NIS

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
Amirnader Emami RazaviGholam Ali Naderi
© 2022 Meta ULC. All rights reserved